VENOFER

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VENOFER contains one active pharmaceutical ingredient (API):

1 Iron sucrose UNII FZ7NYF5N8L - IRON SUCROSE

Iron sucrose is composed of a polynuclear iron(III)-hydroxide core surrounded by a large number of non-covalently bound sucrose molecules. The polynuclear iron core has a structure similar to that of the core of the physiological iron storage protein ferritin. The complex is designed to provide, in a controlled manner, utilisable iron for the iron transport and storage proteins in the body (i.e., transferrin and ferritin, respectively). Read about Iron sucrose

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VENOFER Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10229J, 8807M
Country: CA	Health Products and Food Branch	Identifier(s): 02243716
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2405-MEE-0816
Country: EE	Ravimiamet	Identifier(s): 1133121
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64000
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 099092
Country: FR	Base de données publique des médicaments	Identifier(s): 60080232
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 185386, 186794
Country: HK	Department of Health Drug Office	Identifier(s): 50860
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-398921872
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7259
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004161, 1091008
Country: NL	Z-Index G-Standaard	Identifier(s): 14170965
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 100110, 49948
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11113
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100024167, 100254223, 100399720, 100418707
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51230001, W51230002
Country: SG	Health Sciences Authority	Identifier(s): 11354P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8793011H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514755661
Country: US	FDA, National Drug Code	Identifier(s): 0517-2310, 0517-2325, 0517-2340, 49230-530, 49230-534, 50090-4541
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/8.3/0166